Alkermes

ALKS

Alkermes plc is a biopharmaceutical company that focuses on central nervous system (CNS) diseases such as such as schizophrenia, depression, addiction and multiple sclerosis. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies (EDT), t …

Insider trades and stock quote 2024-2026

All insider trades at Alkermes

Subscribe RSS
Date Type Insider Position Ø-Price Volume
8/3/2026 Sell Gaffin, David Joseph EVP, CLO, Alkermes, Inc. $48.6 $98,812
8/3/2026 Sell Hopkinson, Craig C. EVP R&D, Chief Medical Officer $48.6 $437,220
8/3/2026 Sell Snyderman, Nancy Lynn Md Director $50.3 $2,239,076
7/6/2026 Sell Gaffin, David Joseph EVP, CLO, Alkermes, Inc. $54.0 $109,897
7/1/2026 Sell Hopkinson, Craig C. EVP R&D, Chief Medical Officer $51.8 $463,621
6/12/2026 Sell Wright, Christopher I. Director $45.1 $90,200
6/4/2026 Sell Gaffin, David Joseph EVP, CLO, Alkermes, Inc. $43.0 $87,564
6/1/2026 Sell Hopkinson, Craig C. EVP R&D, Chief Medical Officer $41.7 $375,044
5/29/2026 Sell Parisi, Samuel Joseph VP, Finance (Interim PAO) $42.4 $687,007
5/4/2026 Sell Gaffin, David Joseph EVP, CLO, Alkermes, Inc. $33.2 $67,529
5/1/2026 Sell Hopkinson, Craig C. EVP R&D, Chief Medical Officer $33.4 $300,560
4/6/2026 Sell Gaffin, David Joseph EVP, CLO, Alkermes, Inc. $34.6 $70,315
4/1/2026 Sell Hopkinson, Craig C. EVP R&D, Chief Medical Officer $35.5 $319,604
3/3/2026 Sell Gaffin, David Joseph EVP, CLO, Alkermes, Inc. $29.8 $60,532
3/2/2026 Sell Gaffin, David Joseph EVP, CLO, Alkermes, Inc. $29.3 $59,576
3/2/2026 Sell Hopkinson, Craig C. EVP R&D, Chief Medical Officer $29.7 $267,485
3/2/2026 Sell Nichols, Christian Todd SVP, Chief Commercial Officer $30.0 $180,000
3/2/2026 Sell Parisi, Samuel Joseph VP, Finance (Interim PAO) $29.3 $201,808
2/2/2026 Sell Cooke, Shane Director $34.6 $2,115,672
2/2/2026 Sell Hopkinson, Craig C. EVP R&D, Chief Medical Officer $33.9 $305,385
1/8/2026 Sell Hopkinson, Craig C. EVP R&D, Chief Medical Officer $30.0 $150,005
1/2/2026 Sell Hopkinson, Craig C. EVP R&D, Chief Medical Officer $28.0 $112,000
12/3/2025 Sell Hopkinson, Craig C. EVP R&D, Chief Medical Officer $30.0 $112,447
12/1/2025 Sell Hopkinson, Craig C. EVP R&D, Chief Medical Officer $29.3 $117,200
11/3/2025 Sell Hopkinson, Craig C. EVP R&D, Chief Medical Officer $30.4 $273,442
10/15/2025 Sell Hopkinson, Craig C. EVP R&D, Chief Medical Officer $31.5 $283,776
6/10/2025 Sell Nichols, Christian Todd SVP, Chief Commercial Officer $31.1 $103,654
6/9/2025 Sell Nichols, Christian Todd SVP, Chief Commercial Officer $32.0 $106,489
2/28/2025 Sell Parisi, Samuel Joseph VP, Finance (Interim PAO) $34.0 $65,892
2/25/2025 Sell Parisi, Samuel Joseph VP, Finance (Interim PAO) $35.3 $131,978
2/20/2025 Sell Parisi, Samuel Joseph VP, Finance (Interim PAO) $35.7 $47,361
2/13/2025 Sell Hopkinson, Craig C. EVP R&D, Chief Medical Officer $35.0 $5,130,697
2/12/2025 Sell Hopkinson, Craig C. EVP R&D, Chief Medical Officer $33.0 $6,718,278
1/30/2025 Sell Hopkinson, Craig C. EVP R&D, Chief Medical Officer $32.0 $3,234,382
12/9/2024 Sell Laurencin, Cato T. Director $31.8 $85,708
12/9/2024 Sell Hopkinson, Craig C. EVP R&D, Chief Medical Officer $32.1 $1,961,406
12/5/2024 Sell Hopkinson, Craig C. EVP R&D, Chief Medical Officer $31.5 $290,462
12/4/2024 Sell Hopkinson, Craig C. EVP R&D, Chief Medical Officer $30.8 $441,550
11/27/2024 Sell Nichols, Christian Todd SVP, Chief Commercial Officer $29.2 $151,813
11/11/2024 Sell Hopkinson, Craig C. EVP R&D, Chief Medical Officer $30.1 $1,774,576
11/6/2024 Sell Hopkinson, Craig C. EVP R&D, Chief Medical Officer $29.5 $309,169
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)